Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1982 1
1983 3
1984 3
1985 1
1986 4
1987 2
1988 2
1989 2
1990 1
1991 2
1992 1
1993 3
1994 2
1995 2
1996 5
1997 7
1998 1
1999 3
2000 3
2001 3
2002 2
2003 5
2004 4
2005 3
2006 1
2007 4
2008 4
2009 5
2010 2
2011 4
2012 3
2013 5
2014 3
2015 5
2016 6
2017 3
2018 2
2019 1
2020 5
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Results by year
Filters applied: . Clear all
Page 1
Translation, Pdcd4 and eIF4A.
Biyanee A, Singh P, Klempnauer KH. Biyanee A, et al. Among authors: klempnauer kh. Oncoscience. 2015 Aug 10;2(9):731-2. doi: 10.18632/oncoscience.192. eCollection 2015. Oncoscience. 2015. PMID: 26501070 Free PMC article. No abstract available.
An isoform-specific C/EBPβ inhibitor targets acute myeloid leukemia cells.
Jakobs A, Uttarkar S, Schomburg C, Steinmann S, Coulibaly A, Schlenke P, Berdel WE, Müller-Tidow C, Schmidt TJ, Klempnauer KH. Jakobs A, et al. Among authors: klempnauer kh. Leukemia. 2016 Jul;30(7):1612-5. doi: 10.1038/leu.2016.16. Epub 2016 Feb 8. Leukemia. 2016. PMID: 26854027 No abstract available.
Expression of protein kinase HIPK2 is subject to a quality control mechanism that acts during translation and requires its kinase activity to prevent degradation of nascent HIPK2.
Müller JP, Scholl S, Kunick C, Klempnauer KH. Müller JP, et al. Among authors: klempnauer kh. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118894. doi: 10.1016/j.bbamcr.2020.118894. Epub 2020 Oct 19. Biochim Biophys Acta Mol Cell Res. 2021. PMID: 33091504 Free article.
120 results